Kopra Bio Analysis: $500K Raised
What is Kopra Bio?
Kopra Bio specializes in cancer immunotherapy, transforming cancer cells into biofactories that promote their own destruction.
Founded
2024
Company Stage
Pre-Seed
YC Batch
S24
Product Features & Capabilities
- genetically engineered viruses, viral immunotherapy, treatment for glioblastoma, improves survival from 0% to over 90%, cancer-selective design, strong safety profile, scalable manufacturing
How much Kopra Bio raised
1 - $500K
September 25, 2024Lead Investor: Y Combinator
Who are the founders of Kopra Bio
AB
Andrew Bartynski
Founder
AH
Alexander Haddad
Founder
Investors
- QB3
- Andreessen Horowitz
- Boutique Venture Partners
- Lexi Ventures
- MCMA Ventures
- Pioneer Fund
- Y Combinator
See something that needs updating? Suggest edits to this profile.